Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2 Yoshinori KikuchiHideaki ShimadaHiroyuki Takahashi Special Article 17 March 2024 Pages: 512 - 534
Salivary gland-type cancers: cross-organ demographics of a rare cancer Aika TanzawaKengo SaitoYuichi Takiguchi Original Article Open access 16 March 2024
An approach for improvement of the accuracy of cancer gene panel testing Kiyomi ImotoHiroyuki YamamotoYu Sunakawa Original Article 12 March 2024 Pages: 571 - 581
Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab Masaki HashimotoWataru FukuokayaTakahiro Kimura Original Article 02 March 2024 Pages: 612 - 619
Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a Cancer-VTE Registry subanalysis Mashio NakamuraMasato SakonMasataka Ikeda Original Article Open access 02 March 2024 Pages: 407 - 416
Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study Rikiya TaokaMasaki KamadaMikio Sugimoto Original Article 28 February 2024 Pages: 602 - 611
Current status of head and neck sarcomas in Japan in 2016–2019: an analysis using the national cancer registry Ryoko RikitakeYu MizushimaAkira Kawai Cancer Statistics Open access 27 February 2024 Pages: 564 - 570
Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with HER2-enriched breast cancer Yang LiJun QinXing Sun Original Article 27 February 2024 Pages: 427 - 441
Financial toxicity and patient experience associated with financial burden of molecular-targeted and immune therapies for cancer: an observational study under public health insurance Sena YamamotoChiharu KondohHarue Arao Original Article Open access 24 February 2024 Pages: 417 - 426
Abnormal activation of RFC3, A YAP1/TEAD downstream target, promotes gastric cancer progression Zijun GuoLin Guo Original Article 21 February 2024 Pages: 442 - 455
Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study Yuki KatsuyaTatsuya YoshidaNoboru Yamamoto Original Article Open access 21 February 2024 Pages: 386 - 397
Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021 Hidekatsu NakaiTakahiro HigashiNoriomi Matsumura Cancer Statistics 21 February 2024 Pages: 363 - 371
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan Junji FuruseFumihiko OsugiToshimitsu Endo Original Article Open access 14 February 2024 Pages: 456 - 463
Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study Shigeki KataokaYoshitaka NishikawaManabu Muto Original Article 14 February 2024 Pages: 398 - 406
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022 Eiki IchiharaNobuaki OchiToshio Kubo Special Article 14 February 2024 Pages: 355 - 362
First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the effectiveness using real-world data Hiroki IshiharaKenji OmaeToshio Takagi Original Article 12 February 2024 Pages: 473 - 480
Announcement: Third Joint Committee Report on Diabetes and Cancer Editorial Note 10 February 2024 Pages: 354 - 354
Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy Honami SatoTakahiro KobayashiNaoto Takahashi Original Article Open access 09 February 2024 Pages: 481 - 492
Hydronephrosis severity as a predictor of postoperative renal function decline following laparoscopic radical nephroureterectomy Toru KannoGo KoboriHitoshi Yamada Original Article 06 February 2024 Pages: 464 - 472
Skeletal muscle status and survival among patients with advanced biliary tract cancer Shinya TakaokaTsuyoshi HamadaMitsuhiro Fujishiro Original Article Open access 06 February 2024 Pages: 297 - 308
EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system Kotaro NomuraKeiju AokageMasahiro Tsuboi Original Article 06 February 2024 Pages: 248 - 257
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study Hasan Çağrı YıldırımYasin KutluSercan Aksoy Original Article 04 February 2024 Pages: 258 - 265
Low skeletal muscle radiodensity is a risk factor for adjuvant chemotherapy discontinuation in colorectal cancer Keigo YokoiAkiko WatanabeTakeshi Naitoh Original Article 29 January 2024 Pages: 276 - 285
Adjuvant and neo-adjuvant therapy for non-small cell lung cancer without EGFR mutations or ALK rearrangements Masaru TakenakaKoji KurodaFumihiro Tanaka Invited Review Article 28 January 2024
Impact of sarcopenia on recurrent biliary obstruction after EUS-guided biliary drainage in patients with malignant biliary obstruction Tomoya EmoriMasahiro ItonagaMasayuki Kitano Original Article 27 January 2024 Pages: 286 - 296
The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan Shuhei SuzukiYoshiyuki NagumoHiroyuki Nishiyama Original Article 24 January 2024 Pages: 318 - 324
Predictors for early recurrence beyond up-to-7 or distant metastasis after hepatocellular carcinoma resection: proposal for borderline resectable HCC Norifumi HarimotoMariko TsukagoshiKen Shirabe Original Article 16 January 2024 Pages: 195 - 204
Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902) Tomono KawaseHiroshi ImamuraTaroh Satoh Original Article 16 January 2024 Pages: 134 - 141
Effects of postoperative oral elemental nutritional supplement on skeletal muscle loss after gastrectomy for gastric cancer Kazuhiro NishikawaYutaka KimuraHiroshi Imamura Original Article 16 January 2024 Pages: 266 - 275
Analgesic efficacy and safety of percutaneous thermal ablation plus cementoplasty for painful bone metastases: a systematic review and meta-analysis Tomohiro MatsumotoRika YoshimatsuTakuji Yamagami Original Article 13 January 2024 Pages: 372 - 385
Impact of prostate position-based image-guidance in intensity-modulated radiation therapy for localized prostate cancer Rihito AizawaHaruo InokuchiTakashi Mizowaki Original Article 08 January 2024 Pages: 325 - 332
Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing Kazushige WakudaMeiko MoritaToshiaki Takahashi Original Article 06 January 2024 Pages: 96 - 102
Clinical outcomes of sentinel node navigation surgery in patients with preoperatively estimated stage IA endometrial cancer and evaluation of validity for continuing sentinel node navigation surgery based on dispersion of recurrence probability Tsuyoshi YamashitaTakahiro ItohHideki Satoh Original Article Open access 05 January 2024 Pages: 222 - 231
Glomerular filtration rate measurement during platinum treatment for urothelial carcinoma: optimal methods for clinical practice Dag Rune StormoenUlla Nordström JoensenHelle Pappot Original Article Open access 05 January 2024 Pages: 309 - 317
FOXM1 transcriptional regulation of RacGAP1 activates the PI3K/AKT signaling pathway to promote the proliferation, migration, and invasion of cervical cancer cells Hongye YaoJuan LiJun Yin Original Article 03 January 2024 Pages: 333 - 344
Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer Atsuto MouriKyoichi KairaHiroshi Kagamu Original Article 31 December 2023 Pages: 124 - 133
Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma Hideki GotoSatoshi ItoKoji Izutsu Original Article Open access 29 December 2023 Pages: 232 - 240
Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan Koichi YasudaYusuke UchinamiHidefumi Aoyama Original Article 29 December 2023 Pages: 241 - 247
Treatments and prognostic factors for bone and soft tissue sarcoma in non-urban areas in Japan Nobuko NakamuraShinji HasebeYoshihiro Yakushijin Original Article 28 December 2023 Pages: 345 - 353
Clinical features and distribution of the APC variant in duodenal and ampullary polyps in patients with familial adenomatous polyposis: a multicenter retrospective cohort study in Japan Yasuyuki MiyakuraTatsuro YamaguchiYoichi Ajioka Original Article 24 December 2023 Pages: 169 - 178
Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis Yuto MatsushitaMakito MiyakeHideaki Miyake Original Article 19 December 2023 Pages: 205 - 212
Diagnosis of colorectal cancer based on folate receptor-positive circulating tumor cell analysis: a retrospective cohort study Zhi-jian WeiBai-chuan ZhouA-man Xu Original Article 19 December 2023 Pages: 149 - 158
Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial Sae IshimaruTatsunori ShimoiNoboru Yamamoto Original Article Open access 19 December 2023 Pages: 89 - 95
Current status and future perspective of immunotherapy for renal cell carcinoma Leandro BlasKeisuke MonjiMasatoshi Eto Invited Review Article 18 December 2023
Survival outcome of chemotherapy-naïve castration-resistant prostate cancer treated with new-generation androgen receptor axis-targeted agents in real-world analysis Tatsuya ShimomuraKeiichiro MoriTakahiro Kimura Original Article 16 December 2023 Pages: 213 - 221
Survival outcomes of patients with stage III colorectal cancer aged ≥ 80 years who underwent curative resection: the HiSCO-04 prospective cohort study Tetsuya MochizukiManabu ShimomuraHideki Ohdan Original Article 15 December 2023 Pages: 159 - 168
Prognostic impact and survival outcomes of colon perforation in patients with metastatic colorectal cancer: a multicenter retrospective cohort study Eiichi NakaoHidetaka KawamuraShinichi Konno Original Article 11 December 2023 Pages: 179 - 187
Pegfilgrastim for the management of neutropenia during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer patients Takanori YoshimotoTadayuki OshimaShinichiro Shinzaki Original Article 08 December 2023 Pages: 142 - 148
Risk factors of secondary cancer in laryngeal, oropharyngeal, or hypopharyngeal cancer after definitive therapy Goshi NishimuraHideaki TakahashiNobuhiko Oridate Original Article 07 December 2023 Pages: 103 - 114
Impact of COVID-19 on gynecological cancer incidence: a large cohort study in Japan Hiroaki KomatsuYuji IkedaGynecology Original Article 06 December 2023 Pages: 72 - 77